- EMEA Innovative Medicine
- About us
- Our responsibilities
- Sustainability
- Medicines supply
Medicines supply
To safeguard medicine supply for all patients, we need a coordinated EU approach. EU-wide coordination and harmonization must replace today’s multitude of national approaches. Coordination enables flexible resource allocation to meet patients’ needs. Watch to find out more.
Regulatory flexibilities are needed to create more agile and resilient supply chains. Watch to find out more.
To find out more about the importance of global supply chains,
Watch
You are now leaving jnj.com/innovativemedicine/emea This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use. You are now leaving jnj.com/innovativemedicine/emea This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.

